Posted by Defense World Staff on Feb 21st, 2026
Oncobiologics, Inc. (NASDAQ:OTLK – Free Report) – Brookline Capital Acquisition decreased their Q2 2026 earnings per share estimates for Oncobiologics in a report released on Tuesday, February 17th. Brookline Capital Acquisition...
More of this article »